For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		Reed Elsevier PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			X
An acquisition or disposal of qualifying financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying
financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		Silchester International Investors LLP
	Silchester International Investors International Value Equity
	Taxable Trust
	Silchester International Investors International Value Equity Trust
	Silchester International Investors International Value Equity Group
	Trust
	Silchester International Investors Tobacco Free International Value
4. Full name of shareholder(s)	Equity Trust
(if different from 3.):iv	The Calleva Trust
5. Date of the transaction and date on which the threshold is crossed or
reached: v		8th November 2011
6. Date on which issuer notified:		9th November 2011
7. Threshold(s) that is/are crossed or reached: vi, vii			4	%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B2B0DG97

49,188,704

49,188,704

48,500,738

48,500,738

3.99%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

N/A

N/A

N/A

N/A

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

48,500,738

3.99%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
N/A
Proxy Voting:
10. Name of the proxy holder:		Silchester International Investors LLP
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	Silchester International Investors LLP (“Silchester”) acts as investment manager for the clients detailed in Question 4 above (our “Clients”). In acting for our Clients, Silchester are given full discretion over their investments and are empowered to vote on their behalf. However, we do not act as our Clients’ custodian and therefore shares are not held in our name but in the name of each Client’s custodian bank. The decrease in Silchester’s holdings was due to a series of transactions over a series of different trading days. Details of the number of shares held before the change (shown in Section A ‘Situation previous to the Triggering transaction’ above), represent the shares held by Silchester’s clients as of the date of our last Notice of Substantial Shareholder’s Interest and not as of the last trading day before which this disclosure level was triggered. Notification is provided based on the total voting rights figure of 1,216,558,125
14. Contact name:	Marsha Watson
15. Contact telephone number:	0207 930 7077